Madrigal Pharmaceuticals Inc
F:YDO1
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Madrigal Pharmaceuticals Inc
F:YDO1
|
US |
|
C
|
CAE Inc
F:CE9
|
CA |
|
T
|
Tesla Inc
F:TL0
|
US |
|
M
|
MTN Group Ltd
XMUN:LL6
|
ZA |
|
V
|
Very Good Food Company Inc
DUS:0SI
|
CA |
|
ProPetro Holding Corp
F:2PG
|
US |
|
P
|
Papa John's International Inc
XMUN:PP1
|
US |
|
TMX Group Ltd
TSX:X
|
CA |
|
S
|
Stantec Inc
F:S3A
|
CA |
|
N
|
NVIDIA Corp
XMUN:NVD
|
US |
|
C
|
CH Robinson Worldwide Inc
DUS:CH1A
|
US |
|
Gurit Holding AG
F:GVM0
|
CH |
|
Iridium Communications Inc
NASDAQ:IRDM
|
US |
Wall St Price Targets
YDO1 Price Targets Summary
Madrigal Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for YDO1 is 475.87 EUR with a low forecast of 376.24 EUR and a high forecast of 695.69 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is YDO1's stock price target?
Price Target
475.87
EUR
According to Wall Street analysts, the average 1-year price target for YDO1 is 475.87 EUR with a low forecast of 376.24 EUR and a high forecast of 695.69 EUR.
What is the Revenue forecast for Madrigal Pharmaceuticals Inc?
Projected CAGR
27%
Over the last 13 years, the compound annual growth rate for Revenue has been 102%. The projected CAGR for the next 8 years is 27%.
What is the Gross Profit forecast for Madrigal Pharmaceuticals Inc?
Projected CAGR
26%
The compound annual growth rate for Gross Profit over the next 8 years is 26%.
